France's Sanofi is studying the possibility of performing part of the manufacturing of COVID-19 vaccines for other drugmakers, a spokesman said on Thursday.
Last month, Sanofi and Britain's GlaxoSmithKline said a COVID-19 vaccine they are jointly developing had showed an insufficient immune response in older people, delaying its launch to late next year, in a setback for both companies.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.